Sheldon H. Preskorn, M.D. is Professor and Chair for the Department of Psychiatry and Behavioral Sciences at the University of Kansas School of Medicine - Wichita. He is also the President and Medical Director of the Psychiatric Research Institute, an affiliate of Via Christi Health System in Wichita, Kansas. View Dr. Preskorn's Curriculum Vitae.

A fellow of the American Psychiatric Association and the American Psychopathological Association, Dr. Preskorn has served on advisory committees of the Food and Drug Administration, Veterans Administration, National Institute of Health and National Science Foundation, and currently consults with the Menninger Foundation.

He received his MD degree at the University of Kansas, Kansas City, Kansas. He completed a two year residency in anatomical pathology (with emphasis on neuropathology) and a one year rotating internship in internal medicine and psychiatry at the University of Kansas Medical Center, Kansas City, Kansas. Dr. Preskorn completed his residency in psychiatry at Washington University School of Medicine, St. Louis, Missouri. He has undergraduate training in psychobiology (psychology, biology and chemistry) and post graduate medical training in anatomical pathology (neuropathology), psychiatry, and basic and clinical pharmacology.

An international lecturer and the author of over 250 scientific and professional articles, Dr. Preskorn has received continuous grant funding since 1978 to allow him to conduct research primarily in the areas of psychopharmacology, affective and anxiety disorders, and neuroscience.

His basic pharmacological and neuroscience research has included studies in learning theory, neurochemistry, neurophysiology, histochemistry, electron microscopy, cerebral blood flow and metabolism, positron emission tomography and radioligand binding. His clinical research has included pharmacokinetics and drug development through all clinical phases, starting with "first time in man" studies through registration proceedings.

He has been a principal investigator during the clinical trial development programs of all eight antidepressants either marketed or recommended for approval in the United States in the last 10 years. He has also been involved in the registration process of 7 out of 8 drugs.

His clinical experience has included six years as supervising physician for an acute psychosis ward, six years as Chief of Psychiatry for a university affiliated Veterans Administration Medical Center, and five years as Director of the Outpatient Psychiatric Clinic for the University of Kansas School of Medicine - Wichita.